Hyaluronic Acid in Counteracting Aphthous Stomatitis

Sponsor
University of Urbino "Carlo Bo" (Other)
Overall Status
Completed
CT.gov ID
NCT04884464
Collaborator
(none)
49
1
9.9
4.9

Study Details

Study Description

Brief Summary

Oral mucosal ulcers can determine a real worsening of the quality of life. Conventional therapy usually lasts not less than 2-3 weeks, and carries a high risk of serious side effects; furthermore, ulcers often recur. The use of hyaluronic acid applied as an adhesive gel over the lesions seems to have potential in terms of efficacy and the avoidance of side effects. Of course, hyaluronic acid-based formulations show different effects and tolerability. In this retrospective observational study, the results obtained using a hyaluronic-acid based medical device applied for 14 days to counteract ulcers in adults will be reported.

Condition or Disease Intervention/Treatment Phase
  • Device: Hyaluronic acid-based gel
  • Drug: Chlorhexidine Gluconate

Study Design

Study Type:
Observational
Actual Enrollment :
49 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Clinical Evaluation of a Hyaluronic Acid-based Medical Device in Counteracting Aphthous Stomatitis in Adults
Actual Study Start Date :
Sep 1, 2018
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Hyaluronic acid-based gel

The composition of the gel, ranked by weight is: xylitol, glycerin, Rosa damascena petal extract, xanthan gum, polycarbophil, hyaluronic acid sodium salt (0.24%), pectin, potassium sorbate, sodium benzoate, panthenol, Aloe barbadensis leaf extract, stevia.

Device: Hyaluronic acid-based gel
Dosage: application of an even coat of 1mm thickness Frequency: 3 times/day (after main meals) Duration: 2 weeks

Chlorhexidine gluconate

Chlorhexidine gluconate at a concentration of 0.2%.

Drug: Chlorhexidine Gluconate
Dosage: application of an even coat of 1mm thickness Frequency: 3 times/day (after main meals) Duration: 2 weeks

Outcome Measures

Primary Outcome Measures

  1. Change in number of oral lesions [Day 1; Day 3; Day 6; Day 9; Day 12; Day 14]

    Change from baseline (Day 1) to Day 14 in the number of oral lesions observed in the two groups

  2. Change in size of oral lesions [Day 1; Day 3; Day 6; Day 9; Day 12; Day 14]

    Change from baseline (Day 1) to Day 14 in the size (mm) of oral lesions observed in the two groups

Secondary Outcome Measures

  1. Compliance to treatment [From Day 1 to Day 14]

    Number of daily treatments completed, timing of treatment application (hour of the day)

  2. Side effects to treatment [From Day 1 to Day 14]

    Dosage Record Treatment Emergent Symptom Scale (DOTES). It uses a Likert scale, going from 1 (no side effects) to 4 (severe side effects).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of aphthous stomatitis

  • Healthy for other conditions excluding aphthous stomatitis

Exclusion Criteria:
  • Taking one of the following in the 45 days prior to the beginning of the study: immunosuppressive, cytotoxic, cortisone, antibiotic, antifungal, hormone therapy (including birth control pills).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University fo Urbino Carlo Bo Urbino Italy 61029

Sponsors and Collaborators

  • University of Urbino "Carlo Bo"

Investigators

  • Principal Investigator: Davide Sisti, PhD, University of Urbino "Carlo Bo"

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Davide Sisti, PhD, University of Urbino "Carlo Bo"
ClinicalTrials.gov Identifier:
NCT04884464
Other Study ID Numbers:
  • UniUrb_HyalAcid_2021
First Posted:
May 13, 2021
Last Update Posted:
Jul 22, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Davide Sisti, PhD, University of Urbino "Carlo Bo"
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2021